Thermodynamics of SmMnO3 and SmMn2O5 phases determined by the E.M.F. method

Streszczenie angielskie: Using solid oxide galvanic cells of the type: MnO + Sm2O3 + SmMnO3 / O-2/ Ni + NiO and Mn3O4 + SmMnO3 + SmMn2O5 / O-2 / air the equilibrium oxygen pressure for three-phase equilibria described by the following reactions of formation of ternary phases: MnO + 1/2Sm2O3 + 1/4O2 = SmMnO3 1/3Mn3O4 + SmMnO3 + 1/3O2 = SmMn2O5 was determined in the temperature range from 1173 to 1450 K. From the obtained experimental data the corresponding Gibbs free energy change for above reactions of phases formation was derived: ΔG0f,SmMnO3(+/ - 250J) = -131321(+/ - 2000) + 48.02(+/ - 0:35)T / K ΔG0f,SmMn2O5(+/ - 2000 J) = -107085(+/ - 2200) + 69.74(+/ - 1:70)T / K Using obtained results and available literature data, thermodynamic data tables for the two ternary phases have been compiled from 298.15 to 1400 K. Streszczenie polskie: W pracy przedstawiono wyniki badań dotyczące własności termodynamicznych manganinów samaru, wyznaczone metodą pomiaru SEM ogniw ze stałym elektrolitem: MnO + Sm2O3 + SmMnO3 / O-2/ Ni + NiO ogniwo I Mn3O4 + SmMnO3 + SmMn2O5 / O-2 / powietrze ogniwo II oraz określono równowagowe ciśnienie parcjalne tlenu dla reakcji tworzenia SmMnO3 i SmMn2O5 w zakresie temperatur 1173�1450 K: MnO + 1/2Sm2O3 + 1/4O2 = SmMnO3 1/3Mn3O4 + SmMnO3 + 1/3O2 = SmMn2O5 Z tych danych doświadczalnych wyznaczono zależności temperaturowe energii swobodnych tworzenia powyższych manganinów samaru: ΔG0f,SmMnO3(+/ - 250J) = -131321(+/ - 2000) + 48.02(+/ - 0:35)T / K ΔG0f,SmMn2O5(+/ - 2000 J) = -107085(+/ - 2200) + 69.74(+/ - 1:70)T / K W tablicach I i II zamieszczono dane termodynamiczne dla dwóch potrójnych faz otrzymane poprzez kompilacje własnych danych doświadczalnych z danymi literaturowymi.

Phytomedicinal importance of Saraca asoca (Ashoka): an exciting past, an emerging present and a promising future

Since the dawn of civilization, natural resources have remained the mainstay of various remedial approaches of humans vis-a-vis a large number of illnesses. Saraca asoca (Roxb.) de Wilde (Saraca indica L.) belonging to the family Caesalpiniaceae has been regarded as a universal panacea in old Indian Ayurvedic texts and has especially been used to manage gynaecological complications and infections besides treating haemmorhagic dysentery, uterine pain, bacterial infections, skin problems, tumours, worm infestations, cardiac and circulatory problems. Almost all parts of the plant are considered pharmacologically valuable. Extensive folkloric practices and ethnobotanical applications of this plant have even lead to the availability of several commercial S. asoca formulations recommended for different indications though adulteration of these remains a pressing concern. Though a wealth of knowledge on this plant is available in both the classical and modern literature, extensive research on its phytomedicinal worth using state-of-the-art tools and methodologies is lacking. Recent reports on bioprospecting of S. asoca endophytic fungi for industrial bioproducts and useful pharmacologically relevant metabolites provide a silver lining to uncover single molecular bio-effectors from its endophytes. Here, we describe socio-ethnobotanical usage, present the current pharmacological status and discuss potential bottlenecks in harnessing the proclaimed phytomedicinal worth of this prescribed Ayurvedic medicinal plant. Finally, we also look into the possible future of the drug discovery and pharmaceutical R&D efforts directed at exploring its pharma legacy.